News
They also found vulnerabilities in a Medtronic pacemaker that could allow a hacker to reprogram the device from anywhere – disrupting a patient's heart rhythms in a way that could hurt or kill them.
9don MSN
When patients think of Medtronic, their minds may first wander to pacemakers, but then diabetes products such as insulin ...
After a patient death, the U.S. Food and Drug Administration is warning about a rare battery-depletion problem in certain Medtronic pacemakers that could cause the devices to quickly lose power ...
Although both Aveir DR and Micra AV2 are dual-chamber leadless pacemakers, an analyst believes the former will help Abbott take market share from Medtronic. While Aveir DR hit the market after ...
Medtronic's stock has shown a favorable one-day return following its earnings announcements in 53% of instances.
These patients received a dual-chamber Medtronic pacemaker and were randomized 1:1 (pacemaker on and pacemaker off). The treatment phase of the study demonstrated significant reduction in ...
Medtronic has secured the FDA’s approval for the latest generation of its miniaturized, wireless pacemaker implants, the Micra AV2 and VR2. According to the company, the newest models can offer ...
That, of course, was several years before the revelations about Abbott and Medtronic pacemaker vulnerabilities. The race between hackers and security professionals continues. But the ...
Medtronic has informed health care providers that two of its CareLink pacemaker-programming devices can no longer be updated over internet, citing cybersecurity risks. The medical-device giant ...
Medtronic has a foot in almost every clinical area. The device maker with a market valuation of nearly $100 billion sells pacemakers, spinal cord stimulators, stents, monitors. Name a device ...
The human pacemaker Tara the miniature schnauzer received was donated to the canine by medical device company Medtronic Kelli Bender is the Pets Editor at PEOPLE. She has been working at PEOPLE ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results